Should Medpace’s (MEDP) Golden Cross and Upgraded Estimates Prompt a Fresh Look at Its Valuation?

Medpace Holdings (MEDP) recently experienced a "golden cross" and received upgraded earnings estimates, suggesting positive technical momentum and improved financial prospects. While these developments highlight stronger near-term performance and reinforce the company's backlog conversion, investors should consider the risk of concentrated client exposure and the sustainability of current growth and margin levels. Despite these positive indicators, Medpace's projected fair value suggests a potential downside to its current price.